Aurora Spine Receives 2022 Best New Spine Technology Award for its DEXA bone density-matched spine implant innovation
October 11 2022 - 7:00AM
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:
ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative
medical devices that improve spinal surgery outcomes, today
announced it is the recipient of the Annual Spine Technology Award
for 2022 for its DEXA Technology™ Bone Density-Matched Interbody
Implants.
Aurora’s DEXA Technology was recognized by RRY Publications LLC
and the Orthopedics this Week magazine for its innovative
technology developed to match spinal implants to patients’ bone
density. The award will be handed out at the 37th Annual Meeting of
the North American Spine Society (NASS)
in Chicago, USA.
Aurora Spine’s first-of-its kind DEXA Technology™ is designed to
match a patient’s bone density, promote bone in-growth while
maintaining the biomechanical structure and bone support. This
innovative idea is being utilized to manufacture implants that
match the patient’s specific bone density based on a DEXA
Scan/T-score allowing for the best bone fusion treatment and most
favorable outcome.
Aurora Spine’s DEXA Technology™ is part of the company's
advanced portfolio representing the future of Spinal and Orthopedic
implants. Following fundamental principles of patent focused
innovation, DEXA Technology™ was logically created and patented to
combine the essential design benefits of conventional machining, 3D
printing, and additive implant manufacturing.
"We are honored to receive this prestigious award and the
orthopedic industry’s recognition for our work as our DEXA
Technology™ is the world’s only innovation of its kind that
provides surgeons with additional solutions in selecting the right
implant for their patient," said Trent Northcutt, CEO of Aurora
Spine.
Laszlo Garamszegi, Chief Technology Officer of Aurora Spine,
added “We thank Orthopedics This Week and the
distinguished panel of spine surgeons for the 2022 Best New Spine
Technology Award and for their consideration of Aurora’s DEXA
Technology, which is a tremendous acknowledgement of the hard work
and dedication of our team and our physician partners.”
About Aurora Spine
Aurora Spine is focused on bringing new solutions to the spinal
implant market through a series of innovative, minimally invasive,
regenerative spinal implant technologies.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Forward-Looking Statements
This news release contains forward-looking information that
involves substantial known and unknown risks and uncertainties,
most of which are beyond the control of Aurora Spine, including,
without limitation, those listed under "Risk Factors" and
"Cautionary Statement Regarding Forward-Looking Information" in
Aurora Spine's final prospectus (collectively, "forward-looking
information"). Forward-looking information in this news release
includes information concerning the proposed use and success of the
company’s products in surgical procedures. Aurora Spine cautions
investors of Aurora Spine's securities about important factors that
could cause Aurora Spine's actual results to differ materially from
those projected in any forward-looking statements included in this
news release. Any statements that express, or involve discussions
as to, expectations, beliefs, plans, objectives, assumptions or
future events or performance are not historical facts and may be
forward-looking and may involve estimates, assumptions and
uncertainties which could cause actual results or outcomes to
differ unilaterally from those expressed in such forward-looking
statements. No assurance can be given that the expectations set out
herein will prove to be correct and, accordingly, prospective
investors should not place undue reliance on these forward-looking
statements. These statements speak only as of the date of this
press release and Aurora Spine does not assume any obligation to
update or revise them to reflect new events or circumstances.
Contact:
Aurora Spine Corporation
Trent NorthcuttPresident and Chief Executive Officer(760)
424-2004
Chad ClouseChief Financial Officer(760)
424-2004www.aurora-spine.com
Adam Lowensteiner LYTHAM PARTNERS, LLCPhoenix | New
YorkTelephone: 646-829-9700arosf@lythampartners.com
Aurora Spine (TSXV:ASG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aurora Spine (TSXV:ASG)
Historical Stock Chart
From Apr 2023 to Apr 2024